Pharmacist intervention was associated with lowering patients’ HbA1C levels by 1% after recommending that primary care providers switch medication treatments for their patients, according to research presented at the American Society of Health-System Pharmacists’ midyear meeting. Using information in patients’ electronic health records, pharmacists provided 180 recommendations for 102 patients with diabetes and cardiovascular disease at the Memphis VA Medical Center in Tennessee. Primary care providers followed 23 of those recommendations, which included switching patients from sulfonylureas to a GLP-1 receptor agonist or an SGLT-2 inhibitor, hyperlipidemia interventions, hypertension interventions, and recommendations for tobacco cessation. The average HbA1c levels of 7.7% decreased to 6.7% among the 23 patients who were switched to a different treatment suggested by a pharmacist. However, there are some limitations, such as infrequent patient visits, that may impact how quickly the pharmacist recommendations are accepted.